Prediction of a response of a prostate cancer subject to radiotherapy based on pde4d7 correlated genes
Номер патента: EP4204579A1
Опубликовано: 05-07-2023
Автор(ы): Monique STOFFELS, Ralf Dieter HOFFMANN
Принадлежит: Koninklijke Philips NV
Опубликовано: 05-07-2023
Автор(ы): Monique STOFFELS, Ralf Dieter HOFFMANN
Принадлежит: Koninklijke Philips NV
Реферат: The invention relates to a method of predicting a response of a prostate cancer subject to radiotherapy, comprising determining or receiving the result of a determination of a gene expression profile for each of two or more PDE4D7 correlated genes selected from the group consisting of: ABCC5, CUX2, KIAA1549, PDE4D, RAP1GAP2, SLC39A11, TDRD1, and VWA2, said gene expression profiles being determined in a biological sample obtained from the subject, and determining the 5 prediction of the radiotherapy response based on the gene expression profiles for the two or more PDE4D7 correlated genes.
Methods and systems for determining a pregnancy-related state of a subject
Номер патента: AU2021324778A1. Автор: Maneesh Jain,Farooq SIDDIQUI,Eugeni Namsaraev,Morten Rasmussen,Elaine GEE,Mitsu Reddy,Manfred Lee,Joan Camunas Soler,Arkady Khodursky,Rory Nolan. Владелец: Mirvie Inc. Дата публикации: 2023-04-13.